Kotak Investment Advisors Limited (KIAL), the alternative assets arm of Kotak Mahindra Group, on Tuesday said it has invested up to Rs 400 crore ($47.9 million) in medical device manufacturer Biorad Medisys, through its Strategic Situations India Fund II.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
